No benefit from daratumumab, bortezomib and dexamethasone (D‐Vd) in real‐world patients with functional high‐risk multiple myeloma: A report from the Myeloma and Related Diseases Registry
作者
Sueh‐li Lim,Cameron Wellard,Rajeev Rajagopal,Simon J. Harrison,Amit Khot,Hang Quach,P. Joy Ho,Elizabeth S. Moore,Erica M. Wood,Andrew Spencer